Arotinoid mofarotene (RO40-8757) up-regulates p21 and p27 during growth inhibition of pancreatic cancer cell lines (Q73734393)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9311612%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Arotinoid mofarotene (RO40-8757) up-regulates p21 and p27 during growth inhibition of pancreatic cancer cell lines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9311612%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9311612

17 November 2024

cell cycle proteins

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9311612

17 November 2024

proto-oncogene protein

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9311612

tumor suppressor proteins

17 November 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9311612

17 November 2024

author name string

S. Kawa

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9311612

17 November 2024

T. Nikaido

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9311612

17 November 2024

Y. Aoki

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9311612

17 November 2024

Y. Zhai

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9311612

17 November 2024

T. Kumagaya

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9311612

17 November 2024

K. Furihata

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9311612

17 November 2024

S. Fujii

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9311612

17 November 2024

K. Kiyosawa

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9311612

17 November 2024

language of work or name

English

0 references

publication date

1 September 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9311612%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

4 September 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9311612

full work available at URL

17 November 2024

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F(SICI)1097-0215(19970904)72:5%3C906::AID-IJC31%3E3.0.CO;2-3

1 reference

10.1002/(SICI)1097-0215(19970904)72:5<906::AID-IJC31>3.0.CO;2-3

https://api.crossref.org/works/10.1002/(SICI)1097-0215(19970904)72:5%3C906::AID-IJC31%3E3.0.CO;2-3

https://onlinelibrary.wiley.com/doi/full/10.1002/(SICI)1097-0215(19970904)72:5%3C906::AID-IJC31%3E3.0.CO;2-3

17 November 2024

1 reference

10.1002/(SICI)1097-0215(19970904)72:5<906::AID-IJC31>3.0.CO;2-3

https://api.crossref.org/works/10.1002/(SICI)1097-0215(19970904)72:5%3C906::AID-IJC31%3E3.0.CO;2-3

International Journal of Cancer

17 November 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9311612%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

72

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9311612%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9311612%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

906-911

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9311612%20AND%20SRC:MED&resulttype=core&format=json

All-trans-retinoic acid inhibits growth of human pancreatic cancer cell lines

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970904%2972%3A5%3C906%3A%3AAID-IJC31%3E3.0.CO%3B2-3

Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970904%2972%3A5%3C906%3A%3AAID-IJC31%3E3.0.CO%3B2-3

The E2F transcription factor is a cellular target for the RB protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970904%2972%3A5%3C906%3A%3AAID-IJC31%3E3.0.CO%3B2-3

Ligand specificities of recombinant retinoic acid receptors RAR alpha and RAR beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970904%2972%3A5%3C906%3A%3AAID-IJC31%3E3.0.CO%3B2-3

Inhibitory effect of 220-oxa-1,25-dihydroxyvitamin D3 on the proliferation of pancreatic cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970904%2972%3A5%3C906%3A%3AAID-IJC31%3E3.0.CO%3B2-3

13-cis-Retinoic Acid Plus Interferon -2a: Highly Active Systemic Theraphy for Squamous Cell Carcinoma of the Cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970904%2972%3A5%3C906%3A%3AAID-IJC31%3E3.0.CO%3B2-3

13-cis-Retinoic Acid and Interferon -2a: Effective Combination. Therapy for Advanced Squamous Cell Carcinoma of the Skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970904%2972%3A5%3C906%3A%3AAID-IJC31%3E3.0.CO%3B2-3

Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970904%2972%3A5%3C906%3A%3AAID-IJC31%3E3.0.CO%3B2-3

Antiproliferative effects of the arotinoid Ro 40-8757 in human gastrointestinal and pancreatic cancer cell lines: combinations with 5-fluorouracil and interferon-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970904%2972%3A5%3C906%3A%3AAID-IJC31%3E3.0.CO%3B2-3

The RXR heterodimers and orphan receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970904%2972%3A5%3C906%3A%3AAID-IJC31%3E3.0.CO%3B2-3

Joining the complex: cyclin-dependent kinase inhibitory proteins and the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970904%2972%3A5%3C906%3A%3AAID-IJC31%3E3.0.CO%3B2-3

21 January 2018

Stifled by inhibitions

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970904%2972%3A5%3C906%3A%3AAID-IJC31%3E3.0.CO%3B2-3

Retinoids: effects on growth, differentiation, and nuclear receptor expression in human pancreatic carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970904%2972%3A5%3C906%3A%3AAID-IJC31%3E3.0.CO%3B2-3

Down-regulation of mitochondrial gene expression by the anti-tumor arotinoid mofarotene (Ro 40-8757).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970904%2972%3A5%3C906%3A%3AAID-IJC31%3E3.0.CO%3B2-3

Growth-inhibitory effects of vitamin D analogues and retinoids on human pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970904%2972%3A5%3C906%3A%3AAID-IJC31%3E3.0.CO%3B2-3

21 January 2018

3

47

936

Carmichael

1987

1 reference

10.1002/(SICI)1097-0215(19970904)72:5<906::AID-IJC31>3.0.CO;2-3

https://api.crossref.org/works/10.1002/(SICI)1097-0215(19970904)72:5%3C906::AID-IJC31%3E3.0.CO;2-3

17 November 2024

4

47

943

Carmichael

1987

1 reference

10.1002/(SICI)1097-0215(19970904)72:5<906::AID-IJC31>3.0.CO;2-3

https://api.crossref.org/works/10.1002/(SICI)1097-0215(19970904)72:5%3C906::AID-IJC31%3E3.0.CO;2-3

17 November 2024

19

43

3034

Sporn

1983

1 reference

10.1002/(SICI)1097-0215(19970904)72:5<906::AID-IJC31>3.0.CO;2-3

https://api.crossref.org/works/10.1002/(SICI)1097-0215(19970904)72:5%3C906::AID-IJC31%3E3.0.CO;2-3

17 November 2024

21

53

2319

Teelman

1993

1 reference

10.1002/(SICI)1097-0215(19970904)72:5<906::AID-IJC31>3.0.CO;2-3

https://api.crossref.org/works/10.1002/(SICI)1097-0215(19970904)72:5%3C906::AID-IJC31%3E3.0.CO;2-3

17 November 2024

23

56

264

Wang

1996

1 reference

10.1002/(SICI)1097-0215(19970904)72:5<906::AID-IJC31>3.0.CO;2-3

https://api.crossref.org/works/10.1002/(SICI)1097-0215(19970904)72:5%3C906::AID-IJC31%3E3.0.CO;2-3

17 November 2024

Identifiers

10.1002/(SICI)1097-0215(19970904)72:5<906::AID-IJC31>3.0.CO;2-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9311612%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference